OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Targeting glutamine metabolism as a therapeutic strategy for cancer
Jonghwa Jin, Jun‐Kyu Byun, Yeon‐Kyung Choi, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 4, pp. 706-715
Open Access | Times Cited: 208
Jonghwa Jin, Jun‐Kyu Byun, Yeon‐Kyung Choi, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 4, pp. 706-715
Open Access | Times Cited: 208
Showing 26-50 of 208 citing articles:
The emerging importance of the α-keto acid dehydrogenase complexes in serving as intracellular and intercellular signaling platforms for the regulation of metabolism
Ryan J. Mailloux
Redox Biology (2024) Vol. 72, pp. 103155-103155
Open Access | Times Cited: 6
Ryan J. Mailloux
Redox Biology (2024) Vol. 72, pp. 103155-103155
Open Access | Times Cited: 6
Targeting the glutamine-arginine-proline metabolism axis in cancer
Di Wang, Jiang‐Jie Duan, Yufeng Guo, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2024) Vol. 39, Iss. 1
Open Access | Times Cited: 6
Di Wang, Jiang‐Jie Duan, Yufeng Guo, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2024) Vol. 39, Iss. 1
Open Access | Times Cited: 6
Glutamine Metabolism and Prostate Cancer
Holger H.H. Erb, Nikita Polishchuk, Oleh Stasyk, et al.
Cancers (2024) Vol. 16, Iss. 16, pp. 2871-2871
Open Access | Times Cited: 6
Holger H.H. Erb, Nikita Polishchuk, Oleh Stasyk, et al.
Cancers (2024) Vol. 16, Iss. 16, pp. 2871-2871
Open Access | Times Cited: 6
Metabolic Reprogramming in Glioblastoma Multiforme: A Review of Pathways and Therapeutic Targets
Ashley Irin Cortes Ballen, Maryam Amosu, Surya Ravinder, et al.
Cells (2024) Vol. 13, Iss. 18, pp. 1574-1574
Open Access | Times Cited: 6
Ashley Irin Cortes Ballen, Maryam Amosu, Surya Ravinder, et al.
Cells (2024) Vol. 13, Iss. 18, pp. 1574-1574
Open Access | Times Cited: 6
Deficiency in SLC25A15, a hypoxia-responsive gene, promotes hepatocellular carcinoma by reprogramming glutamine metabolism
Qiangnu Zhang, Wei Teng, Wen Jin, et al.
Journal of Hepatology (2023) Vol. 80, Iss. 2, pp. 293-308
Closed Access | Times Cited: 15
Qiangnu Zhang, Wei Teng, Wen Jin, et al.
Journal of Hepatology (2023) Vol. 80, Iss. 2, pp. 293-308
Closed Access | Times Cited: 15
Intelligent Delivery Systems in Tumor Metabolism Regulation: Exploring the Path Ahead
Xu‐Wen Li, Tao Sun, Chen Jiang
Advanced Materials (2023) Vol. 36, Iss. 11
Closed Access | Times Cited: 14
Xu‐Wen Li, Tao Sun, Chen Jiang
Advanced Materials (2023) Vol. 36, Iss. 11
Closed Access | Times Cited: 14
Altered expression of GLS2 indicates a poor prognosis and correlates with clinicopathological features of oral squamous cell carcinoma
B. Kannan, Chu Pandi, Anitha Pandi, et al.
International Journal of Oral and Maxillofacial Surgery (2024) Vol. 53, Iss. 8, pp. 635-643
Closed Access | Times Cited: 5
B. Kannan, Chu Pandi, Anitha Pandi, et al.
International Journal of Oral and Maxillofacial Surgery (2024) Vol. 53, Iss. 8, pp. 635-643
Closed Access | Times Cited: 5
A redox-responsive prodrug for tumor-targeted glutamine restriction
Céline Prange, Nadia Yasmina Ben Sayed, Bing Feng, et al.
Journal of Controlled Release (2024) Vol. 368, pp. 251-264
Open Access | Times Cited: 5
Céline Prange, Nadia Yasmina Ben Sayed, Bing Feng, et al.
Journal of Controlled Release (2024) Vol. 368, pp. 251-264
Open Access | Times Cited: 5
Exploiting the Achilles’ heel of cancer: disrupting glutamine metabolism for effective cancer treatment
Yuxin Fan, Xue Han, Zhimin Li, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5
Yuxin Fan, Xue Han, Zhimin Li, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5
Metabolic Fingerprint in Childhood Acute Lymphoblastic Leukemia
Maria Papadopoulou, Paraskevi Panagopoulou, Efstathia I. Paramera, et al.
Diagnostics (2024) Vol. 14, Iss. 7, pp. 682-682
Open Access | Times Cited: 5
Maria Papadopoulou, Paraskevi Panagopoulou, Efstathia I. Paramera, et al.
Diagnostics (2024) Vol. 14, Iss. 7, pp. 682-682
Open Access | Times Cited: 5
Glutamine-derived aspartate is required for eIF5A hypusination-mediated translation of HIF-1α to induce the polarization of tumor-associated macrophages
Dongho Kim, Yoo Na Kang, Jonghwa Jin, et al.
Experimental & Molecular Medicine (2024) Vol. 56, Iss. 5, pp. 1123-1136
Open Access | Times Cited: 5
Dongho Kim, Yoo Na Kang, Jonghwa Jin, et al.
Experimental & Molecular Medicine (2024) Vol. 56, Iss. 5, pp. 1123-1136
Open Access | Times Cited: 5
Decoding mitochondria's role in immunity and cancer therapy
Yu Shrike Zhang, Hong Yan, Yuquan Wei, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 4, pp. 189107-189107
Open Access | Times Cited: 5
Yu Shrike Zhang, Hong Yan, Yuquan Wei, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 4, pp. 189107-189107
Open Access | Times Cited: 5
Targeting the glutamine metabolism to suppress cell proliferation in mesenchymal docetaxel-resistant prostate cancer
Alicia-Marie K. Beier, Celina Ebersbach, Tiziana Siciliano, et al.
Oncogene (2024) Vol. 43, Iss. 26, pp. 2038-2050
Open Access | Times Cited: 5
Alicia-Marie K. Beier, Celina Ebersbach, Tiziana Siciliano, et al.
Oncogene (2024) Vol. 43, Iss. 26, pp. 2038-2050
Open Access | Times Cited: 5
Folate-targeted nanoparticles for glutamine metabolism inhibition enhance anti-tumor immunity and suppress tumor growth in ovarian cancer
Shuning Chen, Yu Jiang, Jiao Zheng, et al.
Journal of Controlled Release (2025) Vol. 379, pp. 89-104
Closed Access
Shuning Chen, Yu Jiang, Jiao Zheng, et al.
Journal of Controlled Release (2025) Vol. 379, pp. 89-104
Closed Access
Metabolic Atlas of Human Eyelid Infiltrative Basal Cell Carcinoma
Yanjing Huang, Chengjie He, Qiuling Hu, et al.
Investigative Ophthalmology & Visual Science (2025) Vol. 66, Iss. 1, pp. 11-11
Open Access
Yanjing Huang, Chengjie He, Qiuling Hu, et al.
Investigative Ophthalmology & Visual Science (2025) Vol. 66, Iss. 1, pp. 11-11
Open Access
Glutamic acid–coated zinc oxide nanoparticles: synthesis, characterization, and anticancer activity
Hương Nguyễn Thị, Nguyễn Ngọc Sơn, Vu Minh Thanh, et al.
Journal of Nanoparticle Research (2025) Vol. 27, Iss. 1
Open Access
Hương Nguyễn Thị, Nguyễn Ngọc Sơn, Vu Minh Thanh, et al.
Journal of Nanoparticle Research (2025) Vol. 27, Iss. 1
Open Access
Metabolic programming of pancreatic and colon cancer
Sridevi Mardham, Soumya Dakshinamurthy
Elsevier eBooks (2025), pp. 325-340
Closed Access
Sridevi Mardham, Soumya Dakshinamurthy
Elsevier eBooks (2025), pp. 325-340
Closed Access
Glutamine and cancer: metabolism, immune microenvironment, and therapeutic targets
Ding Nan, Weiping Yao, Luanluan Huang, et al.
Cell Communication and Signaling (2025) Vol. 23, Iss. 1
Open Access
Ding Nan, Weiping Yao, Luanluan Huang, et al.
Cell Communication and Signaling (2025) Vol. 23, Iss. 1
Open Access
SUMO-Specific Peptidase 5 Promotes Oesophageal Squamous Cell Carcinoma Growth through the NF-κB-SLC1A3 Axis
Chaoxiang Du, Yunfan Hu, Xinyu Yang, et al.
Frontiers in Bioscience-Landmark (2025) Vol. 30, Iss. 1
Open Access
Chaoxiang Du, Yunfan Hu, Xinyu Yang, et al.
Frontiers in Bioscience-Landmark (2025) Vol. 30, Iss. 1
Open Access
Targeting Metabolic Vulnerabilities to Combat Drug Resistance in Cancer Therapy
Taranatee Khan, M Nagarajan, Irene Kang, et al.
Journal of Personalized Medicine (2025) Vol. 15, Iss. 2, pp. 50-50
Open Access
Taranatee Khan, M Nagarajan, Irene Kang, et al.
Journal of Personalized Medicine (2025) Vol. 15, Iss. 2, pp. 50-50
Open Access
Anti‐Tumor Strategies Targeting Nutritional Deprivation: Challenges and Opportunities
Jinsheng Shi, Wei Han, Jie Wang, et al.
Advanced Materials (2025)
Closed Access
Jinsheng Shi, Wei Han, Jie Wang, et al.
Advanced Materials (2025)
Closed Access
Harnessing amino acid pathways to influence myeloid cell function in tumor immunity
Jiongli Pan, Yi Lin, Xinyuan Liu, et al.
Molecular Medicine (2025) Vol. 31, Iss. 1
Open Access
Jiongli Pan, Yi Lin, Xinyuan Liu, et al.
Molecular Medicine (2025) Vol. 31, Iss. 1
Open Access
Weight Management for Fertility-Preservation Therapy in Endometrial Cancer: Opportunities and Challenges
Xiaodan Li, YiQian Chen, Xiaowei Li, et al.
Current Oncology Reports (2025)
Closed Access
Xiaodan Li, YiQian Chen, Xiaowei Li, et al.
Current Oncology Reports (2025)
Closed Access
Comprehensive review on glioblastoma: nanotechnology, immunotherapy and combined therapeutic approaches
Ashish Dhiman, ya N A Shah, Dhwani Rana, et al.
RSC Pharmaceutics (2025)
Open Access
Ashish Dhiman, ya N A Shah, Dhwani Rana, et al.
RSC Pharmaceutics (2025)
Open Access
Cryptococcal nutrient acquisition and pathogenesis: dining on the host
John R. Perfect, James W. Kronstad
Microbiology and Molecular Biology Reviews (2025)
Closed Access
John R. Perfect, James W. Kronstad
Microbiology and Molecular Biology Reviews (2025)
Closed Access
